Vidapharma

Vidapharma operates three complementary lines simultaneously: the proprietary Ksurgery brand (medical and cosmetic), a full private-label contract-manufacturing service for third-party clients, and exclusive Italian distribution of Skeyndor, a high-end Spanish aesthetics brand. This triple-model structure is rare in the Italian professional cosmetics market and gives distributors a single partner capable of covering most product-development and brand-management needs within one trusted manufacturer.

All production, formulation, sterile processing and medical-device assembly runs in-house at the Crespina facility in Tuscany — a single integrated site that keeps full traceability and quality control under the company's direct supervision. The Made in Italy status is not a marketing claim but a structural reality of vertically integrated production, with documentation available for distributors serving regulated markets.

The company's medical-device division develops a wide range of hyaluronic acid fillers at different concentrations — engineered for immediate, safe and non-invasive aesthetic results. This injectables capability, combined with topical cosmetic expertise, places Vidapharma in the small set of Italian manufacturers able to serve both aesthetic-medicine clinics and traditional beauty channels from a single source.

Vida's development process is grounded in scientific methodology rather than purely trend-driven formulation — backed by an active presence at major international aesthetic medicine conferences (including EuroMediCom AMWC Monaco) to keep product and technology development aligned with the latest global clinical standards and practitioner expectations.

Ksurgery Laboratories won Best Innovative Product 2024 at the 43rd LNE Cosmetology Congress in Krakow, Poland, for its Essential Mousse Detergente Sensitive — independent international validation of the company's formulation capability. The award demonstrates that the company's innovation is structurally recognisable by international scientific juries, not just locally acknowledged.

Vidapharma recently welcomed private equity firm White Bridge Investments into its capital structure and has previously received Tuscany regional (POR FESR) funding to support plant and inventory investment — including COVID-19 emergency-response capacity expansion. Together these signals represent concrete institutional confidence in the company's expansion plans, a credibility marker for distributors evaluating long-term partnership.

Vida serves as the exclusive Italian distributor for Skeyndor, an established high-end Spanish professional aesthetics brand — extending the company's role beyond manufacturing into premium foreign-brand distribution. This exclusive partnership demonstrates Vida's commercial credibility with international premium brands and provides Italian distributors an additional high-end brand entry through the same trusted supplier.

The private label division offers an end-to-end personalised product development service covering cosmetics, sterile products and medical devices — synchronising in-house laboratory know-how with each client's specific requirements. This depth of customisation is the strongest argument for international distributors and brand owners looking to develop differentiated Made-in-Italy product lines without building their own manufacturing infrastructure.